Introduction
The AML1 gene is located at the breakpoints of several types of chromosomal rearrangements which are associated with human acute myeloid and lymphoblastic leukemia (see reviews by Ito, 1996; Nucifora and Rowley, 1995) . Due to the rearrangements, the chimeric genes are generated between AML1 and the MTG8/ETO, EVI1 or TEL genes (Erickson et al., 1992; Golub et al., 1995; Mitani et al., 1994; Miyoshi et al., 1991 Nucifora et al., 1993; Romana et al., 1995; Shurtle et al., 1995) . The resulting fusion genes are considered to be the activated oncogenes responsible for leukemogenesis. AML1, also known as Pebpa2b or Cbfa2, encodes the DNA binding subunit of the heterodimeric transcription factor, PEBP2/CBF (Bae et al., 1993 Kagoshima et al., 1993; Meyers et al., 1993; Ogawa et al., 1993) . Since the DNA binding domain of AML1, called the Runt domain, is retained in the fusion products, deregulation of PEBP2/CBF dependent transcriptional activation has been suggested to underlie the molecular mechanism of leukemogenesis (Frank et al., 1995; Hiebert et al., 1996; Lenny et al., 1995; Meyers et al., 1995 Meyers et al., , 1996 Tanaka et al., 1995) .
AML1 is involved not only in human leukemogenesis but also in the physiological development of hematopoietic tissues. Gene targeting studies have demonstrated that AML1 is indispensable for the development of de®nitive hematopoiesis in the murine fetal liver (Okuda et al., 1996; Wang et al., 1996) . None of the cells of any hematopoietic lineage, except for the primitive, yolk sac-derived erythrocytes, are detected in the homozygously targeted embryos. Furthermore, chimeric analysis indicates that the AML1 (7/7) embryonic stem cells do not contribute to the formation of any hematopoietic tissues in adult mice. These observations suggest that the defect caused by AML1 targeting is most likely intrinsic to the multipotent hematopoietic progenitors. AML1 (7/7) embryos die on embryonic day 12.5 due to the concomitant and massive hemorrhage of primitive erythrocytes in the central nervous system (Okuda et al., 1996; Wang et al., 1996) . Therefore, gene targeting studies cannot foretell the possible role of AML1 in tissues that grow and dierentiate late in embryonic development. One possibility is that AML1 plays a signi®cant role in T lymphocytes. Firstly, expression of AML1 is detected in abundance in the T cell lines as well as in embryonic and adult thymocytes . Two other mammalian runt genes are known, Pebpa2a/Cbfa1/AML3 and Pebpa2c/Cbfa3/AML2 Levanon et al., 1994; Wijmenga et al., 1995) , both of which also encode the DNA binding subunit of PEBP2/CBF. Their expression in thymus is relatively low compared to that of AML1 Satake et al., 1995) . Secondly, PEBP2/CBF was identi®ed as a binding factor for the enhancer core of murine leukemia virus (MuLV) (Satake et al., 1992; Wang and Speck, 1992) . The Moloney strain of MuLV causes T cell leukemia when injected into newborn mice, whereas mutation of the CBF binding sequence in the virus genome delays the onset of the disease and changes the oncogenic target from T lymphocytes to erythrocytes (Speck et al., l990) . Therefore, PEBP2/ CBF appears to determine the speci®city of target cells to MuLV. Finally, PEBP2/CBF has been implicated in T cell speci®c expression of the T cell receptor (TCR) genes. The enhancer elements of the TCRa, TCRb, TCRg and TCRd genes harbor PEBP2/CBF binding sites (see a review by Leiden, 1993) . In the case of TCRa and TCRb enhancers, PEBP2/CBF and Ets-1 binding sites are located next to each other. Titration experiments demonstrate cooperative binding of the two factors to DNA, thus enhancing their DNA binding anities as well as lowering their dissociation from DNA (Giese et al., 1995; Sun et al., 1995; Wotton et al., 1994) . PEBP2/CBF and c-Myb independently bind to their adjacent sites in the enhancer element of TCRd and activate transcription synergistically in transient expression assays Krangel, 1994, 1995) .
In spite of the above observations, a key function of AML1, if any, in T cell growth, dierentiation and/or death has yet to be described. Also, the nature of the signal induced by AML1 expression in T lymphocytes remains unknown. Recently, PEBP2/CBF has been implicated in transcriptional activation of the granzyme B gene promoter (Wargnier et al., 1995) . This serine protease is found in the granules of activated cytotoxic T cells and natural killer cells, and plays an essential role in the induction of target cell DNA fragmentation (Heusel et al., 1994) . In the present study we used the T hybridoma line as a model to study the activationinduced death of T lymphocytes. TCR signaling mediated apoptosis of the various lines of T hybridoma occurs in two steps. The ®rst step is dependent on expression of the Fas and Fas-ligand genes (Brunner et al., 1995; Dhein et al., 1995; Ju et al., 1995) . Since retinoic acid or dexamethasone treatment, which blocks Fas-ligand but not Fas gene expression, can prevent apoptosis, more critical is the induction of Fas-ligand (Cui et al., 1996; Ju et al., 1995) . The second step following the Fas/Fas-ligand interaction is independent of gene expression and proceeds autonomously with the involvement of ICE-like proteases (Enari et al., 1995; Los et al., 1995) . We show that the AML1 protein, if overexpressed, can function antagonistically against TCR-mediated apoptosis by down regulating Fas-ligand expression. The TCR signaling in such AML1 overproducing cells is directed instead towards the induction of the IL-2 receptor a (IL-2Ra), a manifestation of cell proliferation. The results suggest that the AML1 protein plays a pivotal role in switching TCR signaling between apoptosis and cell proliferation in T lymphocytes.
Results
Exogenously introduced AML1 antagonizes apoptosis mediated by TCR signaling in the T hybridoma It has been established that several lines of T hybridoma including DO11.10 which we used in the present study as a representative are induced to apoptotic death by anti-CD3 antibody treatment (Brunner et al., 1995; Ju et al., 1995) . The function of AML1 protein in the apoptosis, if any, is not known, but one possibility is that, although the AML1 protein could function anti-apoptotically, the amount of protein present endogenously in the DO11.10 cells might not be sucient to counteract the apoptosis. To test a putative anti-apoptotic function of AML1, we arti®cially manipulated AML1 levels inside the cells by introducing AML1 cDNA. An epitope of the¯uvirus hemagglutinin (HA) was tagged to the amino-terminus of murine AML1. A plasmid DNA harboring both the HA-AML1 cDNA and the neomycin resistance gene was electroporated into the DO11.10 cells. After G418 selection, ®ve independent cell clones, namely A1 through to A5, were isolated from 288 wells. The protein extracts were prepared from each clone, gel electrophoresed and processed for immunoblot analysis ( Figure 1a ). As seen in lanes 3 ± 7, the anti-HA antibody detected the 57 kilodalton (kD) bands to various degrees in all the clones except for A1 in which the band was barely visible. The positions of these bands corresponded to the calculated molecular mass of the HA-AML1 polypeptide. Lane 2 contains clone V which represents one of several clones established by transfecting a plasmid harboring only the neomycin resistance gene and by selecting for resistance to G418, whereas lane 1 represents the parental DO11.10 cells. In the extracts from these two clones, no band was detected by the anti-HA antibody at the expected position. The viability and growth curves of the established cell clones were not signi®cantly dierent from those of the parental DO11.10 cells (data not shown).
To examine the DNA binding activity, protein extracts were processed for electrophoretic mobility shift assay (EMSA) (Figure 1b ). In the parental (lane 1) and the vector-only transfected cell clones (lane 3), the DNA binding activity of the endogenous PEBP2/ CBF protein was nearly the same. The speci®city of the band shifts was con®rmed by a competition experiment with unlabeled oligonucleotides (data not shown). In the case of the A2 clone, on the other hand, DNA binding activity had increased approximately threefold (lane 5). As seen in lane 6, preincubation of the A2 extract with the anti-HA antibody generated a supershifted band (indicated by the arrowhead), demonstrating that the increase in the level of the band shift was due to the presence of exogenously expressed AML1 within the DNA-protein complex. A 2 ± 3-fold increase in PEBP2/CBF DNA binding activity was also observed in the A3, A4 and A5 but not in the A1 clone (data not shown). Thus, these results con®rmed that the overexpressed AML1 was functional and contributed to the increase in the PEBP2/CBF DNA binding activity of the cells.
Then, DO11.10 and derivative cell clones were incubated in the anti-CD3 antibody coated wells. At various times following incubation, the cells were harvested and labeled with propidium iodite (PI). Figure 2 shows a time course of the appearance of PI positive cells as analysed by a¯uorescence activated cell sorter (FACS). Up to 6 h after antibody treatment, the percentages of PI positive cells remained low in all the clones. In the parental and neomycin expressing V AML1 in T cell apoptosis M Fujii et al (and three more neomycin only expressing clones also, data not shown for these) and A1 clones, the percentages increased at 12 h and reached a maximum of 50 ± 70% after 24 h of incubation, suggesting that the cells were going to die. To examine whether this re¯ected cell death by apoptosis, genomic DNA was prepared after each incubation period and run on an agarose gel ( Figure 3 ). Ladders of unit-length genomic DNA became apparent at 12 h and thereafter, but only in the parental and neomycin expressing cell clones. Thus, TCR engagement by anti-CD3 treatment caused apoptotic cell death in the DO11.10 cells.
On the other hand, the percentages of PI positive cells did not signi®cantly increase even after 24 h incubation in the four clones that expressed the exogenously introduced HA-AML1 protein (see A2, A3, A4 and A5 in Figure 2 ). In accordance with this, a DNA ladder was not apparent in the A2 clone ( Figure  3) . The results therefore indicate that the AML1 protein, when overexpressed, can antagonize the apoptotic process mediated by TCR signaling. It should be noted that cell surface expression of CD3e and TCRb molecules in the A2 clone was indistinguishable from that of the parental cells as revealed by FACS (data not shown). Thus, the A2 clone was competent for the interaction of the TCR/CD3 complex with the anti-CD3 antibody.
Expression of Fas-ligand and Fas in the AML1 overproducing cell clones
Apoptosis of the various T hybridoma lines is totally dependent on the induction of Fas-ligand gene expression elicited by TCR engagement (Brunner et al., 1995; Cui et al., 1996; Dhein et al., 1995; Ju et al., 1995) . Poly(A) + RNA was prepared from the parental DO11.10 and the A2 clone (nearly identical results were obtained for the A5 clone hereafter, data not shown for this), gel electrophoresed and processed for Figure 1 (a) Immunodetection of the exogenously expressed AML1 protein in the derivative clones of DO11.10. Twenty mg protein was extracted from each clone, electrophoresed on an SDS-polyacrylamide gel and, after transfer, the blotted ®lter was processed for immunoblot analysis using the anti-HA-epitope antibody. The 57 kD bands correspond to the HA-positive AML1 protein. Lane 1 is a parental DO11.10 cell, whereas lane 2 is a G418-resistant cell clone which was transfected with the vector, pCX2neo, harboring the neomycin-resistance gene but not the AML1b cDNA. Lanes 3 ± 7 represent the individually isolated cell clones, A1 to A5, which were established by transfecting DO11.10 cells with a plasmid harboring HA-tagged AML1b cDNA. In lane 8, a plasmid containing HA-AML1b cDNA was transfected transiently into the C2C12 mouse myoblasts. This was used as a positive control because of its very high transfection eciency. (b) PEBP2/CBF DNA binding activities in the cell clones. Four mg of protein was extracted from the parental DO11.10 or the indicated, derivative cell clones and was processed for EMSA. In the even numbered lanes, the extract was preincubated with the anti-HA antibody. The band indicated by an arrowhead represents a supershift of the PEBP2/CBF/DNA complex (Figure 4) . The Fas-ligand transcript was not detected before anti-CD3 treatment but was induced signi®cantly after 3 h of incubation in the parental cells. In contrast, induction of the Fasligand was markedly suppressed in the A2 clone throughout the incubation. The lower panel shows the pro®le of Fas gene expression during anti-CD3 treatment. In the parental DO11.10 cells, a small amount of transcript was observed already in the absence of antibody and this expression increased following anti-CD3 treatment. This up regulation of Fas was also observed in the A2 clone, although expression was delayed and more enhanced than in the parental cells. This result suggests that the resistance of the AML1 overexpressing A2 clone to apoptosis is likely to be due to down regulation of Fas-ligand expression.
Although Fas-ligand was not induced, expression of Fas was strongly up regulated in the A2 clone by the anti-CD3 antibody. If the intracellular apoptotic machinery involving ICE-like proteases remains intact in the A2 clone, then addition of the Fas-ligand to the anti-CD3 treated cells should cause apoptosis. We examined this possibility by using the anti-Fas antibody instead of the Fas-ligand itself. The appearance of PI positive cells after antibody treatment was monitored by FACS ( Figure 5) . Incubation of the A2 clone with either the anti-CD3 or the anti-Fas antibody resulted in no increase or just a slight increase in the percentages of PI positive cells in the population. On the other hand, the simultaneous addition of the anti-CD3 and anti-Fas antibodies caused a signi®cant increase in the percentages of PI positive cells. No signi®cant differences were observed between the concentrations of 1 mg/ml and 4 mg/ml of the anti-Fas antibody, suggesting that the range antibody concentrations used were sucient to saturate all the Fas antigen. The 50% cell death observed after 24 h in the anti-CD3 and antiFas treated A2 clone was less than the 80% cell death of the anti-CD3 treated, parental DO11.10 cells. This dierence in sensitivity might be due to dierent means to elicit death signaling, namely the anti-Fas in the former and the Fas-ligand in the latter. The result indicates that the apoptotic machinery following the Fas/Fas-ligand interaction may indeed function in the A2 clone. Thus, the resistance to apoptosis seen in the AML1 overproducing cells can be attributed mainly to down regulation of Fas-ligand expression. 
Expression patterns of IL-2Ra and the other apoptosisrelated genes
Incubation of the A2 clone with the anti-CD3 antibody did not cause apoptosis after 48 h and even resulted in a slight increase in viable cell number (data not shown). Induction of IL-2Ra expression can be taken as an indicator of proliferative TCR signaling. We therefore examined IL-2Ra expression by Northern blot analysis (Figure 6 ). The IL-2Ra transcripts were not detected in the parental DO11.10 cells throughout anti-CD3 treatment. On the other hand, expression was clearly induced in the A2 clone after antibody treatment. The result indicates that overexpression of AML1 changes TCR signaling from the apoptotic, Fasligand expression pathway to the proliferative, IL-2Ra expression pathway. The expression patterns of the apoptosis-related genes other than Fas/Fas-ligand were also examined by Northern blot analysis (Figure 6 ). The 7.5 and 2.4 kilobases (kb) Bcl-2 transcripts indicated by arrows were not detected in the parental cells prior to anti-CD3 treatment and were induced moderately following antibody stimulation. This induction was more clearly observed in the A2 clone. Interestingly, a signi®cant amount of Bcl-2 expression was detected before anti-CD3 stimulation in the A2 clone. This result indicates that overexpression of AML1 increases Bcl-2 expression, independently of TCR signaling. The band indicated by the arrowhead corresponds to 28S rRNA and is due to cross-hybridization of the probe as described in the literature (Negrini et al., 1987) .
The Bcl-x and Bax transcripts were detected in the absence of the anti-CD3 antibody and were induced moderately following stimulation. There appeared to be no major dierences in the expression of the two genes between the parental cell and the A2 clone, except that Bax was induced more rapidly in the former than in the latter. Thus, the results in Figure 6 indicate that overexpression of AML1 aects expression of IL-2Ra and Bcl-2 but not signi®cantly that of Bcl-x and Bax.
Discussion
In AML1 overexpressing DO11.10 derivatives, we could demonstrate that down regulation of Fas-ligand induction was the basis of their resistance to TCRmediated apoptosis. Another important feature observed in the AML1 overexpressing clones was the induction of IL-2Ra by anti-CD3 treatment, something that was never seen in the parental DO11.10 cells. How does AML1 regulate expression of Fas-ligand and IL2Ra ? Since AML1 is the DNA binding subunit of the PEBP2/CBF transcription factor, one possibility is that AML1 directly interacts with the promoters of Fasligand and IL-2Ra. If this were the case, AML1 could repress the activity of the Fas-ligand promoter on the one hand, and activate the IL-2Ra promoter on the other hand. NFkB and/or NF-AT transcription factors have been implicated in the regulation of the promoters of Fas-ligand and IL-Ra (Ivanov et al., 1997; Latinis et al., 1997; Sperisen et al., 1995) . Although almost all the transient expression studies reported so far have shown that AML1 functions as a transcriptional activator Frank et al., 1995; Hiebert et al., 1996; Meyers et al., 1995; Nuchprayoon et al,. 1994; Sun et al., 1995; Takahashi et al., 1995; Uchida et al., 1997; Zhang et al., 1996) , some sort of interaction between AML1 and NFkB/NF-AT could still down regulate the Fas-ligand promoter. We reported previously that the Runt protein of Drosophila can function as an active repressor in some cases (Fujioka et al., 1996) . However, a search of the 400 bp 5'-anking region of the transcription initiation site of murine Fas-ligand or IL-2Ra did not reveal a typical PEBP2/CBF recognition sequence (unpublished observation).
The concomitant down regulation of the Fas-ligand and up regulation of the IL-2Ra by overexpressed Figure 6 Northern blot analysis of IL-2Ra and apoptosis-related genes in the DO11.10 and the derivative, AML1 overproducing cell clone. Poly(A) + RNA was prepared from the DO11.10 and the A2 clone at the indicated times after anti-CD3 antibody treatment and processed for Northern blot analysis. The probes used to detect each transcript were as indicated. The bands indicated by the arrows in the Bcl-2 panel represent the Bcl-2 transcripts as judged by their sizes, whereas the bands indicated by the arrowhead correspond to 28S rRNA that cross-hybridized the probe. This cross-hybridization has been previously described in the literature (Negrini et al., 1987) AML1 in T cell apoptosis M Fujii et al AML1 points to a more plausible explanation. We hypothesize that the AML1 protein, although its direct target gene(s) is not known at present, somehow plays an essential role in determining whether cells survive or die, irrespective of TCR signaling. At limiting amounts of AML1, the cells would be destined for apoptosis, whereas at increased levels the cells would survive. In accordance with this hypothesis is the observation that the expression of Bcl-2, an anti-apoptotic gene, was up regulated in the AML1 overproducing clones prior to anti-CD3 treatment. As far as TCR signaling is concerned, it could be either directed towards apoptotic or proliferative pathways, depending on the predetermined fate of the cells. Thus, overexpression of AML1 likely changes a quality of TCR signaling from the Fas-ligand expression pathway to the IL-2Ra expression pathway.
Nur77 and the related TINUR, both of which belong to orphan steroid receptor group, are involved in the induction of apoptosis in T cell hybridomas (Liu et al., 1994; Okabe et al., 1995; Woronicz et al., 1994) . Here, TCR signaling causes expression of these genes and enhances their DNA binding activity. A dominant negative or an antisense form of Nur77 can antagonize this apoptosis (Liu et al., 1994; Woronicz et al., 1994) . Therefore, AML1 and Nur77 appear to have opposite functions, namely negative and positive functions, respectively, in the apoptosis of T hybridomas. It must be noted that no signi®cant changes in PEBP2/ CBF DNA binding activity could be detected in the parental DO11.10 cells throughout the incubation period with the anti-CD3 antibody (data not shown). The amount of AML1 protein present endogenously in these cells is probably below the level sucient to counteract the apoptosis.
In the case of Nur77, its dominant negative form was shown to perturb antigen-induced negative selection, when it was expressed in thymus as a transgene (Calnan et al., 1995) . The Fas and Fasligand dependent apoptotic system is essential for clonal deletion of autoreactive, peripheral T cells in vivo Watanabe-Fukunaga et al., 1992a) . Expression of AML1 is detected not only in thymocytes but also in splenic T cells unpublished observation) . If AML1 is involved in the apoptosis of thymic and/or peripheral T cells, it would be interesting to study its function within this context.
Materials and methods

Cell culture
A murine T cell line, DO11.10, was maintained in RPMI 1640 medium supplemented with 10% (vol/vol) fetal calf serum, 4 mM L-glutamine and 50 mM 2-mercaptoethanol. The hybridoma cell line, 145-2C11, which produces monoclonal hamster IgG directed against the mouse CD3 epsilon molecules, was cultivated in RPMI 1640 medium supplemented with 10% (vol/vol) fetal calf serum, 2 mM Lglutamine, 1 mM sodium pyruvate and 50 mM 2-mercaptoethanol. The anti-CD3 antibody was puri®ed and concentrated by passing the tissue culture supernatant of 145-2C11 through an A-Gel Protein A-Agarose anity column (Bio Rad). Antibody-coated tissue culture plates were prepared as follows. Each well of a 12 well plate of the¯at bottom type (suspension culturing grade, Sumilon) were immersed in 1 ml of the anti-CD3 antibody solution (3 mg/ml in 50 mM Tris-HCl, pH 9.5) and left at 48C overnight. The solution was aspirated and the wells were rinsed three times with phosphate buered saline (PBS). Three ml of 1610 5 cells/ml was placed in each well for activation. The concentration of the anti-mouse Fas monoclonal antibody (Jo2, Pharmingen) added to the medium was 1 or 4 mg/ml.
Plasmid DNA
The pCX2neoaB1 plasmid expressing a murine AML1b/ PEBP2aB1 protein was described previously (Sakakura et al., 1994 ). An epitope of¯uvirus hemagglutinin, the HAtag, was fused to the amino-terminus of AML1b/ PEBP2aB1 by the PCR method as follows. PCR was performed on pCX2neoaB1 template DNA using as a sense primer, 5'-ccggaattcaccatgtatccatatgatgttccagattatgcatgtatccccgtagatg-3', and as an antisense primer, 5'-ccggaattctcagtagggccgccacac-3'. Singly and doubly underlined sequences in the sense primer represent the HA epitope and the codon of the initiating methionine of AML1b/ PEBP2aB1, respectively, whereas the underlined sequence in the antisense primer represents the termination codon. The extreme 5' sequences of both primers harbor the EcoRI sites. The PCR product was subcloned into the EcoRI site of pCX2neo (Niwa et al., 1991) and the resulting plasmid was designated pCX2neo HA/aB1. The authenticity of the modi®ed sequences in the derivative plasmid was con®rmed by a dideoxy-sequencing method.
DNA transfection and isolation of cell clones
Thirty mg of linearized plasmid DNA was electroporated (310 Volt, 975 mF, BioRad Gene Pulser) into 1610 7 of DO11. 10 cells in K-PBS buer (30.8 mM NaCl, 120.7 mM KCl, 8.1 mM Na 2 HPO 4 and 1.46 mM KH 2 PO 4 ). The cells were washed once with the medium and resuspended in 20 ml of fresh medium. An aliquot of cell suspension was plated at 0.2 ml per well in a 96 well plate and incubated for 24 h. G418 was added at 1.6 mg/ml and the cells were incubated for a further 24 days with changing the G418-containing media every day. The surviving cell clones were expanded and used in the experiments. From each of three transfections of pCX2neoHA/aB1 and pCX2neo, ®ve and four clones, respectively, were obtained from 288 wells, the equivalent of three 96 well plates.
Northern blot analysis
The cytoplasmic poly(A) + RNA was prepared from 1610 7 cells, using a Quick Prep Micro mRNA Puri®cation Kit (Pharmacia Biotech). One mg of poly(A) + RNA was separated on a 1% (wt/vol) agarose gel containing 2.2 M formaldehyde. Transfer of RNA onto a Hybond N membrane (Amersham) and the procedures of hybridization and washing were as described previously . The DNA fragments used to make probes were as follows; an EcoRI/AccI fragment from murine Fas cDNA (nt 1 ± 1250, Watanabe-Fukunaga et al., 1992b), a 940 bp XbaI fragment from murine Fas-ligand cDNA harboring the open reading frame , a 430 bp PstI fragment from murine IL-2Ra cDNA harboring the amino-terminal half portion of the open reading frame (Shimizu et al., 1985) and a KpnI fragment of b-actin cDNA (nt 1 ± 1150, Minty et al., 1981) . The DNA fragments to make probes for detecting the Bcl-2, Bcl-x and Bax transcripts were prepared by PCR ampli®cation using the P19 cell or mouse brain derived cDNAs as templates. The primers used in PCR (Moser et , 1997) were as follows; for Bcl-2, 5'-cttgacagaagatcatgccgtcc-3' and 5'-gtatgtacttcatcacgatctcc-3', for Bcl-x, 5'-gagtttgaactgcggtaccgg-3' and 5'-ttccgactgaagagtgagcce-3', and for Bax, 5'-gagacacctgagctgaccttgg-3' and 5'-tcagcccatcttcttccagatgg-3'. The PCR products were puri®ed by agarose gel electrophoresis and 32 P-labeled using a multiprimer labeling kit (Amersham).
Immunoblot analysis
Protein was extracted from 1610 7 of the cells by a ureaTriton method as follows. The cells were suspended in 1 ml of PBS, 0.1 ml of ice-cold 100% (wt/vol) trichloroacetic acid was added and the mixture was kept on ice for 30 min. After centrifugation, the pellet recovered was dissolved in 80 ml of 9 M urea, 2% (vol/vol) TritonX-100 and 1% (wt/ vol) dithiothreitol. Then, 20 ml of 0.37 M lithium dodecylsulfate and 5 ml of 1 M Tris-HCl, pH 8.0 were added and the mixture was sonicated. An aliquot corresponding to 20 mg protein was separated by electrophoresis on a 0.1% (wt/vol) SDS-8% (wt/vol) polyacrylamide gel. Transfer of the proteins from the gel onto the ®lter, the blocking reaction, incubation of the ®lter with the antibodies and visualization of the immunocomplexes using ABC kit and ECL detection reagents were as described previously . The primary antibody was 500-folddiluted, anti-HA mouse monoclonal antibody (clone 12CA5, Boehringer Mannheim), whereas the secondary antibody was 1000-fold-diluted, biotin-conjugated antimouse IgG antibody (Vector Laboratories, Inc.).
EMSA
The procedures for preparing whole cell extract and for EMSA were as previously described . The PEBP2/CBF binding sequence from polyomavirus enhancer was used as a probe to detect PEBP2/CBF DNA binding activity. In a supershift analysis, 5 ml of the extract containing 4 mg protein was incubated with 1 ml of threefold-diluted, anti-HA mouse monoclonal antibody for 30 min on ice and the mixture was processed for EMSA. In competition analysis, a 100-fold molar excess of unlabeled oligonucleotides harboring the wild type or mutated PEBP2/CBF binding site was included in the binding mixture for EMSA.
FACS analysis
Viability of the DO11.10 and derivative clones following anti-CD3 antibody treatment was monitored as follows. The pellet from 3610 5 cells was suspended in 1 ml of PBS containing 0.2% (wt/vol) bovine serum albumin. The suspension was ®ltrated through a nylon mesh of 40 mm diameter to remove cell aggregates, and then immediately analysed by¯ow cytometry after adding 25 ml of propidium iodite (Sigma) solution (50 mg/ml). To detect cell surface CD3e, and TCRb molecules, the¯uorescein-labeled monoclonal antibodies 145-2C11 and H57-597 (Pharmingen) were used, respectively. The analytical FACS used was EPICS-XL (Coulter) and the data was analysed by a software, MacLAS.
Measuring fragmentation of genomic DNA
The cell pellet from 1610 6 cells was suspended in 200 ml of PBS. Ten ml each of Proteinase K (10 mg/ml) and RNase A (10 mg/ml) and 20 ml of 10% (wt/vol) SDS were added and the mixture was incubated at 378C for 30 min. Three hundred ml of a solution containing 6 M NaI, 13 mM EDTA, 0.5% (wt/vol) sodium lauroylsarcosinate, 10 mg/ ml of glycogen and 26 mM Tris-HCl, pH 8.0 was then added and the mixture was incubated at 608C for 15 min. DNA was recovered from the mixture by isopropanol precipitation. An aliquot of the DNA sample was electrophoresed through a 2.0% (wt/vol) agarose gel and the gel was stained by ethidium bromide.
